Pharma Industry News

Why pharma megamergers may become a relic of the past

Despite pent up M&A demand, FTC scrutiny has had a chilling effect on pharma’s appetite for striking major deals.

Despite pent up M&A demand, FTC scrutiny has had a chilling effect on pharma’s appetite for striking major deals.

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

Leave a Comment

[mwai_chat window="true" fullscreen="true"]